Copyright: Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.! 京ICP备19006400号-1 Powered by 300.cn
美科
Links:
Stemedica Cell Technologies, Inc., a US company with investment from JZT, started recruiting patients for its Phase II COVID-19 study.
Source:
Release time:
2021/08/05 14:15
Page view
Stemedica Cell Technologies, Inc., a US company with investment from JZT, started recruiting patients for its Phase II COVID-19 study.